EUVIMEDEUVIMED entdecken
Crossref

DNA Ploidy as a Potential Adjunct Prognostic Marker of Low-Risk Prostate Cancer Progression after Radical Prostatectomy.

Miha Pukl, Matthieu George, Arash Javanmardi, Anita Carraro, Jagoda Korbelik, Rebecca White, Calum MacAulay, Branko Palcic, Mira Keyes, Metka Volavšek, Martial Guillaud

Urology journal./Urology jornal. · 24.03.2024 · 21 (2) · 80-86

DOI: 10.22037/uj.v20i.7324 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Urology journal./Urology jornal., erschienen am 24.03.2024. Verfasst von Miha Pukl und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, GH Celje, 3000 Celje, Slovenia. mihapukl82@gmail.com. Hauptthemen laut MEDLINE: Prostate-Specific Antigen, Prostatic Neoplasms.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Post prostatectomy PSA kinetics and General Grade Groups (GGG) are the strongest prognostic markers of biochemical recurrence (BCR) and prostate cancer (PCa)-specific mortality after radical prostatectomy. Despite having low-risk PCa, some patients will experience BCR, for some, clinically significant BCR. There is a need for an objective prognostic marker at the time of prostatectomy to improve risk stratification within this population. In this study, we investigated the prognostic potential of DNA ploidy. MATERIALS AND METHODS: Prostatectomy samples from 97 patients with GGG1 and GGG2 with a low-risk CAPRA-S score were included in this study. PCa tissue with the worst Gleason pattern underwent tissue disaggregation, cell isolation and staining with a DNA stoichiometric stain. Using image cytometry, DNA ploidy was measured and a Ploidy Score (PS) was generated. RESULTS: Among the 97 patients, 79 had no BCR, 18 experienced BCR, of which 14 had a PSA doubling time (PSA-DT) >1 year (low-risk group) and 4 had a PSA-DT of

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostate-Specific AntigenProstatic NeoplasmsMaleHumansPrognosisNeoplasm Recurrence, LocalProstatectomyPloidiesDNA

Substanzen

Prostate-Specific AntigenDNA

Autor:innen und Institutionen

  • Department of Urology, GH Celje, 3000 Celje, Slovenia. mihapukl82@gmail.com.
  • Department of Integrative Oncology, BC Cancer, Vancouver, BC, Canada. mathieu.george25113@gmail.com.
  • Department of Integrative Oncology, BC Cancer, Vancouver, BC, Canada. arashj1997@gmail.com.
  • Department of Integrative Oncology, BC Cancer, Vancouver, BC, Canada. acarraro@bccrc.ca.
  • Department of Integrative Oncology, BC Cancer, Vancouver, BC, Canada. jkorbeli@bccrc.ca.
  • Department of Integrative Oncology, BC Cancer, Vancouver, BC, Canada. rebecca.white@bccancer.bc.ca.

Zitieren

APA

Pukl, M., George, M., Javanmardi, A., Carraro, A., Korbelik, J., White, R., MacAulay, C., Palcic, B., Keyes, M., Volavšek, M., & Guillaud, M. (2024). DNA Ploidy as a Potential Adjunct Prognostic Marker of Low-Risk Prostate Cancer Progression after Radical Prostatectomy. Urology journal./Urology jornal., 21(2), 80-86. https://doi.org/10.22037/uj.v20i.7324

Vancouver

Pukl M, George M, Javanmardi A, Carraro A, Korbelik J, White R, et al. DNA Ploidy as a Potential Adjunct Prognostic Marker of Low-Risk Prostate Cancer Progression after Radical Prostatectomy. Urology journal./Urology jornal.. 2024;21(2):80-86. doi:10.22037/uj.v20i.7324

BibTeX
@article{Pukl2024,
  author = {Pukl, Miha and George, Matthieu and Javanmardi, Arash and Carraro, Anita and Korbelik, Jagoda and White, Rebecca and MacAulay, Calum and Palcic, Branko and Keyes, Mira and Volavšek, Metka and Guillaud, Martial},
  title = {DNA Ploidy as a Potential Adjunct Prognostic Marker of Low-Risk Prostate Cancer Progression after Radical Prostatectomy},
  journal = {Urology journal./Urology jornal.},
  year = {2024},
  volume = {21},
  number = {2},
  pages = {80--86},
  doi = {10.22037/uj.v20i.7324}
}
Kostenlos starten →